HB 666 Maryland House of Delegates · 2017 Regular Session

Public Health - Expensive Drugs - Manufacturer Reporting and Drug Price Transparency Advisory Committee

Bill status in committee 1 of 4 stages cleared

Introduction

Feb 2017

Committee Review

Floor Vote

Governor

Introduced Feb 1, 2017 Last action Feb 8, 2017

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

2

Key actions

0

Committee

1

Feb 1, 2017

Committee

First Reading Health and Government Operations

legislature

1 primary · 55 co-sponsors

Sponsors

Role

Legislator

Party

State

District

Eric M. Bromwell

Alfred C. Carr, Jr.

Ana Sol Gutierrez

Bonnie Cullison

Brooke E. Lierman